Consistent with the fact that MET is a transmembrane RTK, we also observed in both diagnostic biopsies and P/D specimens that the expression of MET was predominantly in the membrane of tumor cells, though a certain positivity was also visible to a lesser extent in the cytoplasm (Figure 2). This evidence concerns the gene MET and neoplasm.